ABT ABBOTT LABORATORIES

NYSE abbott.com


$ 133.46 $ 1.89 (1.44 %)    

Tuesday, 14-Oct-2025 16:55:09 EDT
QQQ $ 598.02 $ -4.01 (-0.67 %)
DIA $ 462.92 $ 2.03 (0.44 %)
SPY $ 662.01 $ -0.81 (-0.12 %)
TLT $ 90.67 $ 0.29 (0.32 %)
GLD $ 381.38 $ 2.70 (0.71 %)
$ 133.27
$ 131.75
$ 132.30 x 38
$ 134.00 x 50
$ 131.23 - $ 133.34
$ 109.70 - $ 139.95
8,089,238
na
231.95B
$ 0.58
$ 16.59
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-30-2025 06-30-2025 10-Q
2 04-30-2025 03-31-2025 10-Q
3 02-21-2025 12-31-2024 10-K
4 10-31-2024 09-30-2024 10-Q
5 07-31-2024 06-30-2024 10-Q
6 05-02-2024 03-31-2024 10-Q
7 02-16-2024 12-31-2023 10-K
8 11-01-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-17-2023 12-31-2022 10-K
12 11-01-2022 09-30-2022 10-Q
13 08-02-2022 06-30-2022 10-Q
14 05-03-2022 03-31-2022 10-Q
15 02-18-2022 12-31-2021 10-K
16 11-03-2021 09-30-2021 10-Q
17 08-04-2021 06-30-2021 10-Q
18 05-05-2021 03-31-2021 10-Q
19 02-19-2021 12-31-2020 10-K
20 11-04-2020 09-30-2020 10-Q
21 07-29-2020 06-30-2020 10-Q
22 04-29-2020 03-31-2020 10-Q
23 02-21-2020 12-31-2019 10-K
24 10-31-2019 09-30-2019 10-Q
25 07-31-2019 06-30-2019 10-Q
26 05-01-2019 03-31-2019 10-Q
27 02-22-2019 12-31-2018 10-K
28 10-31-2018 09-30-2018 10-Q
29 08-01-2018 06-30-2018 10-Q
30 05-02-2018 03-31-2018 10-Q
31 02-16-2018 12-31-2017 10-K
32 11-02-2017 09-30-2017 10-Q
33 08-02-2017 06-30-2017 10-Q
34 05-03-2017 03-31-2017 10-Q
35 02-17-2017 12-31-2016 10-K
36 11-03-2016 09-30-2016 10-Q
37 08-03-2016 06-30-2016 10-Q
38 05-04-2016 03-31-2016 10-Q
39 02-19-2016 12-31-2015 10-K
40 11-05-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 retail-investors-top-stocks-with-earnings-this-week-fastenal-asml-tsmc-and-more

Retail investors are preparing for the kick-off of the Q3 earnings season, with big banks and other top stocks reporting this w...

 benchmark-initiates-coverage-on-abbott-laboratories-with-buy-rating-announces-price-target-of-145

Benchmark analyst Bruce Jackson initiates coverage on Abbott Laboratories (NYSE:ABT) with a Buy rating and announces Price T...

 evercore-isi-group-maintains-outperform-on-abbott-laboratories-raises-price-target-to-144

Evercore ISI Group analyst Vijay Kumar maintains Abbott Laboratories (NYSE:ABT) with a Outperform and raises the price targe...

 the-magnificent-7-boom-just-triggered-a-dot-com-era-warning

The Magnificent Seven tech giants are now worth $21 trillion—8x more than top health care stocks, echoing dot-com bubble extremes.

 short-report-alleges-dexcom-sold-faulty-g7-device-cited-by-fda

Dexcom faces mounting scrutiny over G7 safety concerns, FDA violations, financial practices, and growing competition from Abbot...

 abbott-receives-ce-mark-for-expanded-navitor-tavi-indication-now-approved-in-europe-for-severe-aortic-stenosis-across-all-surgical-risk-categories

Navitor is now approved as a minimally invasive alternative to surgery for patients in Europe with symptomatic, severe aortic s...

 eu-rushes-to-scrap-tariffs-on-us-goods-to-unlock-lower-american-auto-duties-these-exporters-stand-to-gain-big

EU set to scrap tariffs on U.S. goods in a key auto trade deal. See which American industrial and energy stocks are poised for ...

 abbott-secures-thailand-approval-for-first-denosumab-biosimilar-enhancing-access-to-bone-disease-therapies

 -Reuters 

 this-new-etf-brings-out-the-best-in-sp-500-without-the-tech-overload

Xtrackers SPXD ETF offers a balanced way to invest in S&P 500 without relying on tech giants like Nvidia. Its innovative ap...

 wells-fargo-maintains-overweight-on-abbott-laboratories-lowers-price-target-to-142

Wells Fargo analyst Lawrence Biegelsen maintains Abbott Laboratories (NYSE:ABT) with a Overweight and lowers the price targe...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION